Language

News topic

Expected end: 2027-05

All current shortage notices related to Expected end: 2027-05, structured by product, country, active ingredient and reporting period.

16 notices

← All shortages

Belgium

Naropin 5 mg/ml inj. sol. i.thec. amp. 5 x 10 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Tadalafil Mylan 5 mg film-coat. tabl. 98

Active ingredient: Tadalafil

View notice details →
Belgium

Tadalafil Mylan 5 mg film-coat. tabl. 28

Active ingredient: Tadalafil

View notice details →
Belgium

Tadalafil Mylan 20 mg film-coat. tabl. 4

Active ingredient: Tadalafil

View notice details →
Belgium

Tadalafil Mylan 20 mg film-coat. tabl. 24

Active ingredient: Tadalafil

View notice details →
Belgium

Tadalafil Mylan 20 mg film-coat. tabl. 12

Active ingredient: Tadalafil

View notice details →
Belgium

Esomeprazole Viatris 20 mg hard gastro-resist. caps. 100

Active ingredient: Esomeprazole

View notice details →
Austria

Urbason solubile 250 mg Trockenampullen mit Lösungsmittel

Active ingredient: NATRIUM METHYLPREDNISOLON SUCCINAT

View notice details →
Belgium

Esomeprazole Viatris 20 mg hard gastro-resist. caps. 56

Active ingredient: Esomeprazole

View notice details →
Belgium

Esomeprazole Viatris 20 mg hard gastro-resist. caps. 28

Active ingredient: Esomeprazole

View notice details →
Belgium

Esomeprazole Viatris 40 mg hard gastro-resist. caps. 28

Active ingredient: Esomeprazole

View notice details →
Belgium

Seroquel XR 50 mg tabl. verl. afgifte 10

Active ingredient: Quetiapine

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.